Usafsam/PH - roche immuno and ctng BPA reagents, kits and consumables.
Active Blanket Purchase Agreement Awarded Last action
- Contract number
- FA239625AB002
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Air Force
Department of Defense
- Task orders
- 10 $3,354,486 obligated
Award facts
- Combined order value
- $3,354,486 Current and potential, with all options
- Last date to order 38% complete
- IDV ceiling 9% used
- $37,000,000.00
- Maximum order
- $500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded a single-award Blanket Purchase Agreement valued at $37 million to Roche Diagnostics Corporation, effective December 1, 2024, through November 30, 2029. This BPA establishes pre-negotiated pricing and terms for the procurement of immunology and clinical testing reagents, kits, and consumables, including specialized diagnostics for Chlamydia trachomatis and Neisseria gonorrhoeae detection. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, Indiana, specializing in in vitro diagnostic solutions and laboratory instruments, will perform all work at its facility in Castleton, Indiana, with some task orders executed at Wright-Patterson Air Force Base in Ohio. The award was made through open competition without set-aside designation, leveraging Roche's established GSA Schedule contracts and extensive federal healthcare contracting experience.
Under this BPA vehicle, the Defense Health Agency has issued multiple firm fixed-price task orders since the agreement's inception, totaling approximately $3.67 million across ten calls issued between May 2025 and September 2025. These calls support the Military Health System's laboratory and diagnostic testing operations, providing immunochemistry reagents and consumables essential for routine clinical testing and infectious disease screening across military medical facilities. Roche's contract portfolio with federal healthcare agencies demonstrates consistent capability delivery for molecular diagnostics, clinical chemistry analysis, immunochemistry testing platforms, and specialized reagent supplies. The BPA structure enables efficient acquisition of critical diagnostic products through pre-negotiated terms, ensuring sustained availability of laboratory supplies to support military healthcare delivery and medical readiness across the Department of Defense.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract FA239625AB002?
FA239625AB002 was awarded to Roche Diagnostics Corporation by Air Force (Department of Defense) on December 1, 2024.
How much is contract FA239625AB002 worth?
Orders under FA239625AB002 have obligated $3,354,486. FA239625AB002's own ceiling is $37,000,000. A single order can be worth up to $500,000.
How many orders have been placed under contract FA239625AB002?
10 orders have been placed under FA239625AB002, the latest on September 21, 2025.
Which agency awarded contract FA239625AB002?
Air Force (Department of Defense) awarded FA239625AB002, with funding from Defense Health Agency (Department of Defense).
Who can order from contract FA239625AB002?
FA239625AB002 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV